Open AccessCAR+ T-cell therapy might serve as a new treatment option for Cisplatin resistant squamous cell carcinoma
Author(s) -
Z Poschinski,
C Haist,
Alexandra Hamacher,
Matthias U. Kassack,
Helmut Hanenberg,
Kathrin Scheckenbach
Publication year - 2021
Publication title -
laryngo-, rhino-, otologie
Language(s) - English
Resource type - Conference proceedings
eISSN - 1438-8685
pISSN - 0935-8943
DOI - 10.1055/s-0041-1727938
Subject(s) - cisplatin , chimeric antigen receptor , immunotherapy , medicine , head and neck squamous cell carcinoma , oncology , cancer research , radiation therapy , refractory (planetary science) , basal cell , cell , cell therapy , chemotherapy , head and neck cancer , cancer , biology , genetics , astrobiology